PRESENTERS
Teresa M. Kruisselbrink, MS, CGC (Main Presenter)
PRESENTERS BIO
Konstantinos N. Lazaridis, MD
Carlson and Nelson Endowed Executive Director, Center for Individualized Medicine
Consultant, Gastroenterology
Mayo Clinic, Rochester
Matthew J. Ferber, PhD
Director, Clinical Genome Sequencing Laboratory
Consultant, Laboratory Medicine and Pathology
Mayo Clinic, Rochester
Teresa Kruisselbrink is a Licensed Certified Genetic Counselor, supervisor, and co-director for the Genomics in Action Strategic Initiative in the Center for Individualized Medicine at Mayo Clinic in Rochester, MN. She and her team collaborate to discover, translate and apply new individualized medicine tools and services across the three sites of the Mayo Clinic enterprise.
Konstantinos Lazaridis, M.D., serves as the Carlson and Nelson Endowed Executive Director, Mayo Clinic Center for Individualized Medicine. Dr. Lazaridis is a consultant in the Division of Gastroenterology and Hepatology, Department of Internal Medicine at Mayo Clinic, with a joint appointment in the Department of Clinical Genomics.
Matthew Ferber, PhD, is a Consultant in the Department of Laboratory Medicine and Pathology, and a CEO of sorts for Mayo Clinic GeneGuide, the interpretive engine for the Tapestry program and beyond. He has a real passion for bringing the benefits of genomic medicine to patients around the world.
Tapestry is a Mayo Clinic research study, which includes receiving genetic sequencing data from Helix, up to the full whole exome dataset. The goal of this study is to provide: (i) an immediate interpretation of ancestry/genealogy and several non-disease traits, as well as, clinically actionable variants for an inherited form of high cholesterol called familial hypercholesterolemia (FH), breast and ovarian cancer (HBOC), and Lynch syndrome to each participant; (ii) an additional subset of focused clinically actionable genetic findings, such as, certain types of hereditary cancers, hereditary heart conditions and severe responses to certain medications, will be returned to the provider and to the participant, via the provider, genetic counselor consultation, and/or Mayo Clinic research interpretation; (iii) storing of genomic and phenotypic data for future research analysis.
LEARNING OBJECTIVES
Upon conclusion of this activity, learners should be able to:
ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.
TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.
QUESTIONS?
Contact Coordinator Chris Scott 507-284-0426

Facebook
X
LinkedIn
Forward